Thomas Steyer’s Alpine Immune Sciences Inc ALPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-5,900
Closed -$234K 190
2024
Q1
$234K Buy
+5,900
New +$174K ﹤0.01% 141
2021
Q1
Sell
-200,000
Closed -$2.52M 250
2020
Q4
$2.52M Sell
200,000
-541,290
-73% -$5.31M 0.02% 131
2020
Q3
$6.52M Buy
+741,290
New +$6.78M 0.05% 106

Thomas Steyer's ALPN Position: Q2 2024 in Review

Thomas Steyer sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 5,900 shares — an estimated $234K sold.

Thomas Steyer first reported a position in ALPN in Q3 2020 and held it in 3 quarters. The position peaked at $6.52M in Q3 2020. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

  • Thomas Steyer reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
  • Thomas Steyer sold 5,900 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $234K.
  • Thomas Steyer first reported a position in Alpine Immune Sciences Inc in Q3 2020 and held it in 3 quarters.
  • Thomas Steyer's Alpine Immune Sciences Inc position peaked at $6.52M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Farallon Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.